Title : Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma.

Pub. Date : 2020 Feb

PMID : 31772331






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Accordingly, sensitivity of the CD40L-stimulated cells to S63845 was substantially restored by co-treatment with venetoclax, the BCL-XL-specific inhibitor or ibrutinib. ibrutinib CD40 ligand Homo sapiens